Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 104601-104650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03887988
Orbital Fractures Registry
N/AActive, not recruiting
300 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2025
2 conditions1 sponsor14 locations
NCT05018988
Vitamin D in School Children
NARecruiting
118 participants
Started: Nov 1, 2019 · Completed: Oct 30, 2025
3 conditions3 sponsors1 location
NCT05868863
Percutaneous Cementoplasty With or Without Screw Fixation
N/ARecruiting
40 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04155346
Prehab for Surgery
NAActive, not recruiting
150 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2024
2 conditions3 sponsors1 location
NCT04050280
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
PHASE2Recruiting
39 participants
Started: Nov 1, 2019 · Completed: Feb 28, 2027
3 conditions2 sponsors1 location
NCT02581085
Tocotrienol Against the Progression of End Stage Liver Disease
PHASE2Active, not recruiting
70 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2028
3 conditions3 sponsors1 location
NCT03935958
Curcumin in Kidney Transplant Recipients
NAActive, not recruiting
14 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04022109
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
N/ARecruiting
5,000 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2026
4 conditions12 sponsors5 locations
NCT06173427
Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD
N/ARecruiting
180 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT03791086
The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping
N/ARecruiting
1,000 participants
Started: Nov 1, 2019 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT04082234
Reducing Disparities in Behavioral Health Treatment for Children in Primary Care
NAActive, not recruiting
300 participants
Started: Nov 1, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT04126785
High-Intensity Interval Versus Moderate-Intensity Continuous Water Based Exercise in Hypertensive Older Individuals
NARecruiting
60 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03940209
Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries
PHASE2Active, not recruiting
473 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2024
1 condition3 sponsors1 location
NCT05101824
Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease
NAActive, not recruiting
67 participants
Started: Nov 1, 2019 · Completed: Nov 1, 2027
3 conditions1 sponsor6 locations
NCT04221997
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
PHASE4Recruiting
150 participants
Started: Nov 1, 2019 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04217733
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
PHASE3Recruiting
60 participants
Started: Nov 1, 2019 · Completed: Dec 30, 2030
1 condition1 sponsor1 location
NCT04128644
Thoughts and Health - Preventing Depression in Adolescents
NARecruiting
40 participants
Started: Nov 1, 2019 · Completed: Jan 31, 2025
3 conditions1 sponsor1 location
NCT04549610
HMB and Exercise-induced Muscle Damage
PHASE2/PHASE3Recruiting
30 participants
Started: Nov 1, 2019 · Completed: Jan 1, 2025
5 conditions3 sponsors1 location
NCT05911451
Optimizing Access Surgery In Senior Hemodialysis Patients
NAActive, not recruiting
166 participants
Started: Nov 1, 2019 · Completed: Mar 31, 2026
6 conditions2 sponsors20 locations
NCT04250753
Assessment of Gait Parameters and Their Impact on Postoperative Recovery in Patients with Lumbar Spinal Stenosis
N/ARecruiting
20 participants
Started: Nov 1, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04088773
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease
N/AActive, not recruiting
232 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors4 locations
NCT04037735
RSA-RCT: Attune S+ TKA Versus Sigma TKA
NARecruiting
64 participants
Started: Nov 1, 2019 · Completed: Jun 1, 2026
4 conditions2 sponsors1 location
NCT04454892
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
N/ARecruiting
3,000 participants
Started: Nov 1, 2019 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT05785988
Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)
N/ARecruiting
600 participants
Started: Nov 1, 2019 · Completed: Nov 10, 2024
2 conditions2 sponsors1 location
NCT04672174
Cognitive Screening of Patients with Hearing Loss
NAEnrolling by invitation
20 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04153058
Clinical Outcomes of Robotic Versus Laparoscopic Assisted Radical Gastrectomy for Advanced Siewert II/III AEG
NAEnrolling by invitation
300 participants
Started: Nov 1, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04433299
Back Pain - Linking Phenotype to Pain Mechanism and Outcome.
N/ARecruiting
150 participants
Started: Nov 1, 2019 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT04100733
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
NAActive, not recruiting
392 participants
Started: Nov 1, 2019 · Completed: Apr 30, 2027
2 conditions2 sponsors3 locations
NCT03401593
Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients
NANot yet recruiting
135 participants
Started: Oct 31, 2019 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT04166565
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
PHASE2Active, not recruiting
41 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2027
2 conditions2 sponsors8 locations
NCT04110327
An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease
N/AActive, not recruiting
300 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2028
2 conditions1 sponsor10 locations
NCT04175301
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
PHASE2Active, not recruiting
15 participants
Started: Oct 31, 2019 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04036682
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
284 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2026
2 conditions1 sponsor64 locations
NCT04328233
Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome
NAActive, not recruiting
30 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2024
5 conditions4 sponsors1 location
NCT04130542
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
PHASE1Active, not recruiting
276 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors7 locations
NCT03891784
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
PHASE2Active, not recruiting
20 participants
Started: Oct 31, 2019 · Completed: Sep 30, 2027
9 conditions2 sponsors2 locations
NCT05671666
Ureagenesis Analysis in Healthy Subjects and in Urea Cycle Disorder Patients
NARecruiting
100 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2035
1 condition1 sponsor1 location
NCT04099823
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
NARecruiting
50 participants
Started: Oct 31, 2019 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT03959085
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
PHASE3Recruiting
4,997 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2030
5 conditions2 sponsors230 locations
NCT04130737
TORUS 2 IDE Clinical Study
NAActive, not recruiting
188 participants
Started: Oct 31, 2019 · Completed: Dec 24, 2024
1 condition3 sponsors32 locations
NCT03787680
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
PHASE2Active, not recruiting
49 participants
Started: Oct 31, 2019 · Completed: Aug 31, 2028
1 condition1 sponsor3 locations
NCT04057378
Optimal Electrical Stimulus During Electroconvulsive Therapy
PHASE4Recruiting
800 participants
Started: Oct 30, 2019 · Completed: Nov 15, 2027
2 conditions1 sponsor1 location
NCT04072042
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
PHASE2Recruiting
30 participants
Started: Oct 30, 2019 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT05770765
Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
N/ARecruiting
60,000 participants
Started: Oct 30, 2019 · Completed: Oct 30, 2059
1 condition1 sponsor1 location
NCT03926949
Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients
NARecruiting
60 participants
Started: Oct 30, 2019 · Completed: Jul 31, 2026
2 conditions2 sponsors2 locations
NCT04099394
Pain & Aging: Combined Interventions for Fitness in the Community Study
NAActive, not recruiting
280 participants
Started: Oct 30, 2019 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT04589598
Femoral Neck System and Multiple Cannulated Screws in Femoral Neck Fracture
NAActive, not recruiting
620 participants
Started: Oct 30, 2019 · Completed: Oct 30, 2025
1 condition2 sponsors1 location
NCT04148430
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
PHASE2Active, not recruiting
62 participants
Started: Oct 30, 2019 · Completed: Oct 31, 2025
3 conditions1 sponsor2 locations
NCT04058756
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
PHASE1Active, not recruiting
120 participants
Started: Oct 30, 2019 · Completed: Apr 30, 2030
1 condition1 sponsor48 locations
NCT04108624
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
NAActive, not recruiting
56 participants
Started: Oct 30, 2019 · Completed: Feb 1, 2026
1 condition1 sponsor1 location